Find Information Faster:
PHT is reinventing the eCOA industry. Bookmark this page for the latest corporate, product, award, and event updates.
PHT helps pharmaceutical clients collect compliant patient-driven eData through innovation and education
Webinar reviews science and safety advantages of ePRO for episodic and preventative treatment strategies
Innovator in eClinical research technologies and services poised for continued growth
Dr. Mira Pavlovic-Ganascia, Deputy Director of the Health Technology Assessment Division at Haute Autorité de Santé (HAS) France will present “Endpoints for Reimbursement” at the upcoming PRO & eCOA Congress Europe.
Second consecutive year Mr. Lee is cited for achievement in promoting the adoption of eClinical technologies to advance clinical research
Pharmaceutical sponsors and CROs leverage MyStudyHome™ to boost investigator site engagement and global compliance
Innovators to discuss mobile heath, PRO and eCOA technology for Diabetes studies plus importance of leveraging social communities for enhanced patient recruitment and protocol compliance
Pharmaceutical community innovators to highlight best practices, strategy, and regulatory topics at Europe’s premier patient reported outcomes meeting dedicated to advancing the collection of compliant patient-driven eData
Webinar reviews unique advantages of ePRO data in global diabetes programs
Brings 20+ years of business analytics and project management expertise to sponsor and CRO clinical research programs
BOSTON, Mass. and GENEVA, Switzerland – March 21 – PHT Corporation announced that Elizabeth Ricci, Vice President of Engineering, Technical Support & Data Quality Management, will participate in the Women@Wentworth Symposium in Boston March 23.
Innovators in pharmaceutical industry to join representatives from FDA, sponsors, CROs and sites at forum to advance eClinical research
BOSTON, Mass. and GENEVA, Switzerland – February 21 – PHT Corporation’s Europe General Manager Valdo Arnera, MD will discuss the benefits of eClinical technologies at industry conferences in February and March. PHT is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research.
Policy and compliance expert to discuss FDA perspective on compliant use of ePRO instruments.
Webinar highlights scientific literature based best practices and Regulatory Guidance for researchers incorporating Patient Reported Outcomes and Instruments in adult oncology trials.
FDA policy and compliance expert to address March 26-28 Baltimore patient reported outcomes meeting.
Global pharmaceutical industry adoption of PHT ePRO and eCOA systems accelerate as company achieves 600th clinical research program